Cellectar Biosciences, Inc. Earnings Per Share, Basic and Diluted
Cellectar Biosciences, Inc. (CLRB) reported Earnings Per Share, Basic and Diluted of -$0.11 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-09
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.11.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.13.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.15.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.26.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.76.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.84.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for fiscal 2018 was -$5.23.
- Cellectar Biosciences, Inc. earnings per share, basic and diluted for fiscal 2017 was -$10.70.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed | Earnings Per Share, Basic and Diluted 104 month | Earnings Per Share, Basic and Diluted 107 month | Earnings Per Share, Basic and Diluted 110 month | Earnings Per Share, Basic and Diluted 113 month | Earnings Per Share, Basic and Diluted 116 month | Earnings Per Share, Basic and Diluted 119 month | Earnings Per Share, Basic and Diluted 122 month | Earnings Per Share, Basic and Diluted 125 month | Earnings Per Share, Basic and Diluted 128 month | Earnings Per Share, Basic and Diluted 131 month | Earnings Per Share, Basic and Diluted 134 month | Earnings Per Share, Basic and Diluted 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.11 10-Q · filed 2021-08-09 | -$0.25 10-Q · filed 2021-08-09 | ||||||||||||||||||
| 2021-03-31 | -$0.13 10-Q · filed 2021-05-10 | |||||||||||||||||||
| 2020-12-31 | -$0.76 10-K · filed 2021-03-02 | |||||||||||||||||||
| 2020-09-30 | -$0.15 10-Q · filed 2020-11-09 | -$0.69 10-Q · filed 2020-11-09 | ||||||||||||||||||
| 2020-06-30 | -$0.26 10-Q · filed 2021-08-09 | -$0.65 10-Q · filed 2021-08-09 | ||||||||||||||||||
| 2020-03-31 | -$0.42 10-Q · filed 2021-05-10 | |||||||||||||||||||
| 2019-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$0.78 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$1.84 10-K · filed 2021-03-02 | |||||||||||||||||
| 2019-09-30 | -$0.42 10-Q · filed 2020-11-09 | -$1.51 10-Q · filed 2020-11-09 | ||||||||||||||||||
| 2019-06-30 | -$0.46 10-Q · filed 2020-08-10 | -$1.15 10-Q · filed 2020-08-10 | ||||||||||||||||||
| 2019-03-31 | -$0.76 10-Q · filed 2020-05-07 | |||||||||||||||||||
| 2018-12-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$2.16 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$5.23 10-K · filed 2020-03-09 | |||||||||||||||||
| 2018-09-30 | -$1.65 10-Q · filed 2019-11-12 | -$5.29 10-Q · filed 2019-11-12 | ||||||||||||||||||
| 2018-06-30 | -$1.69 10-Q · filed 2019-08-12 | -$3.75 10-Q · filed 2019-08-12 | ||||||||||||||||||
| 2018-03-31 | -$2.07 10-Q · filed 2019-05-06 | -$0.21 10-Q · filed 2018-05-11 | ||||||||||||||||||
| 2017-12-31 | -$3.22 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$5.87 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$10.70 10-K · filed 2019-02-26 | -$1.07 10-K · filed 2018-03-21 | ||||||||||||||||
| 2017-09-30 | -$2.58 10-Q · filed 2018-11-13 | -$0.26 10-Q · filed 2017-11-09 | -$7.30 10-Q · filed 2018-11-13 | -$0.73 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2017-06-30 | -$2.32 10-Q · filed 2018-08-10 | -$0.23 10-Q · filed 2017-08-14 | -$4.72 10-Q · filed 2018-08-10 | -$0.47 10-Q · filed 2017-08-14 | ||||||||||||||||
| 2017-03-31 | -$0.24 10-Q · filed 2018-05-11 | |||||||||||||||||||
| 2016-12-31 | -$2.14 10-K · filed 2018-03-21 | -$1.36 10-K · filed 2017-03-15 | ||||||||||||||||||
| 2016-09-30 | -$0.43 10-Q · filed 2017-11-09 | -$1.02 10-Q · filed 2017-11-09 | ||||||||||||||||||
| 2016-06-30 | -$0.49 10-Q · filed 2017-08-14 | -$0.50 10-Q · filed 2017-08-14 | ||||||||||||||||||
| 2016-03-31 | $0.96 10-Q · filed 2017-05-11 | |||||||||||||||||||
| 2015-12-31 | -$7.03 10-K · filed 2017-03-15 | |||||||||||||||||||
| 2015-09-30 | -$2.46 10-Q · filed 2016-11-10 | -$0.25 10-Q · filed 2015-11-12 | -$8.53 10-Q · filed 2016-11-10 | -$0.85 10-Q · filed 2015-11-12 | ||||||||||||||||
| 2015-06-30 | -$3.02 10-Q · filed 2016-08-11 | -$0.30 10-Q · filed 2015-08-12 | -$6.07 10-Q · filed 2016-08-11 | -$0.61 10-Q · filed 2015-08-12 | ||||||||||||||||
| 2015-03-31 | -$0.30 10-Q · filed 2015-05-20 | |||||||||||||||||||
| 2014-12-31 | -$17.53 10-K/A · filed 2016-10-20 | -$1.77 10-K · filed 2015-03-24 | ||||||||||||||||||
| 2014-09-30 | $0.06 10-Q · filed 2015-11-12 | -$0.10 10-Q · filed 2014-11-12 | -$1.31 10-Q · filed 2015-11-12 | -$1.54 10-Q · filed 2014-11-12 | ||||||||||||||||
| 2014-06-30 | -$0.73 10-Q · filed 2015-08-12 | -$1.75 10-Q · filed 2015-08-12 | ||||||||||||||||||
| 2014-03-31 | -$1.03 10-Q · filed 2015-05-20 | -$0.05 10-Q · filed 2014-05-14 | -$2.40 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$2.86 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$3.58 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$2.93 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | -$1.38 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$1.83 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$2.55 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$3.86 10-K · filed 2015-05-20 | -$0.19 10-K · filed 2014-03-19 | -$2.90 10-K · filed 2014-03-19 | ||||||||||||||
| 2013-09-30 | -$0.46 10-Q · filed 2015-05-20 | -$0.02 10-Q · filed 2013-11-13 | -$1.18 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$2.47 10-Q · filed 2015-05-20 | -$0.12 10-Q · filed 2013-11-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2015-05-20 | -$2.82 10-Q · filed 2013-11-13 | |||||||||||||
| 2013-06-30 | -$0.72 10-Q · filed 2014-08-04 | -$0.04 10-Q · filed 2013-08-12 | -$2.03 10-Q · filed 2014-08-04 | -$0.10 10-Q · filed 2013-08-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2014-08-04 | -$0.29 derived: net income ÷ weighted average shares · filed 2014-08-04 | -$2.91 10-Q · filed 2013-08-12 | |||||||||||||
| 2013-03-31 | -$0.07 10-Q · filed 2014-05-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$0.18 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$2.97 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2014-03-19 | -$0.11 derived: net income ÷ weighted average shares · filed 2014-03-19 | -$0.16 derived: net income ÷ weighted average shares · filed 2014-03-19 | -$0.23 10-K · filed 2014-03-19 | -$2.91 10-K · filed 2013-03-28 | |||||||||||||||
| 2012-09-30 | -$0.06 10-Q · filed 2013-11-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2013-11-13 | -$0.18 10-Q · filed 2013-11-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2013-11-13 | -$2.92 10-Q · filed 2012-11-06 | |||||||||||||||
| 2012-06-30 | -$0.06 10-Q · filed 2013-08-12 | -$0.12 10-Q · filed 2013-08-12 | -$0.19 derived: net income ÷ weighted average shares · filed 2013-08-12 | -$0.26 derived: net income ÷ weighted average shares · filed 2013-08-12 | -$2.90 10-Q · filed 2012-08-09 | |||||||||||||||
| 2012-03-31 | -$0.06 10-Q · filed 2013-05-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2013-05-15 | -$0.20 derived: net income ÷ weighted average shares · filed 2013-05-15 | -$2.87 10-Q · filed 2012-05-04 | ||||||||||||||||
| 2011-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2013-03-28 | -$0.14 derived: net income ÷ weighted average shares · filed 2013-03-28 | -$0.31 10-K · filed 2013-03-28 | -$2.84 10-K · filed 2012-03-09 | ||||||||||||||||
| 2011-09-30 | -$0.07 10-Q · filed 2012-11-06 | -$0.25 10-Q · filed 2012-11-06 | -$2.80 10-Q · filed 2011-11-07 | |||||||||||||||||
| 2011-06-30 | -$0.10 10-Q · filed 2012-08-09 | -$0.18 10-Q · filed 2012-08-09 | -$2.74 10-Q · filed 2011-08-12 | |||||||||||||||||
| 2011-03-31 | -$0.08 10-Q · filed 2012-05-04 | |||||||||||||||||||
| 2010-12-31 | -$0.36 10-K · filed 2012-03-09 | |||||||||||||||||||
| 2010-09-30 | -$0.05 10-Q · filed 2011-11-07 | -$0.32 10-Q · filed 2011-11-07 | ||||||||||||||||||
| 2010-06-30 | -$0.13 10-Q · filed 2011-08-12 | -$0.27 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |